| Accession Number | 0001193125-26-295106 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Drug Discovery | Common Stock | โ | Jul 1, 2026 | Exercise/Conversion | 3,333 | $2.76 | $9,199.08 | 99,745 | Direct | โ | View Details | |
SVP, Drug Discovery | Common Stock | โ | Jul 1, 2026 | Sale | 2,100 | $34.10 | $71,602.44 | 97,645 | Direct | โ | View Details | |
SVP, Drug Discovery | Common Stock | โ | Jul 1, 2026 | Sale | 1,233 | $34.81 | $42,925.79 | 96,412 | Direct | โ | View Details | |
SVP, Drug Discovery | Stock Option (Right to Buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 3,333 | $0.00 | $0.00 | 7,043 | Direct | โ | View Details |